Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if DMAC is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
13 top institutions tracked
Last 13F trend: unchanged (light)
Unlock crowding heatmapUnlock filer discoverySentiment: unknown
No recent insider trades detected.
Red flags: 3
89 filers reported a long position in DMAC for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| COOPERMAN LEON G | $24.3M | 3.5M | +70.8% |
| BlackRock, Inc. | $15.9M | 2.3M | +21.3% |
| GEODE CAPITAL MANAGEMENT, LLC | $6.3M | 894.1K | +14.6% |
| MILLENNIUM MANAGEMENT LLC | $6M | 845.3K | -9.6% |
| STATE STREET CORP | $4.6M | 646.7K | +0.4% |
| Bleichroeder LP | $2.7M | 382.3K | Unchanged |
| VANGUARD CAPITAL MANAGEMENT LLC | $2.5M | 355.5K | +6.6% |
| OSAIC HOLDINGS, INC. | $2.4M | 338.1K | +5.8% |
| NORTHERN TRUST CORP | $2.3M | 327.5K | -3.3% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1.8M | 251.7K | +23.7% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.